Cite
HARVARD Citation
Harrington, K. et al. (2021). Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040. Journal of the National Cancer Institute. pp. 171-181. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Harrington, K. et al. (2021). Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040. Journal of the National Cancer Institute. pp. 171-181. [Online].